<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;ff=20240107090717&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;utm_medium=rss
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;ff=20240107090717&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;utm_medium=rss" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0)</generator>
<language>en</language>
<lastbuilddate>Sun, 07 Jan 2024 14:07:18 +0000</lastbuilddate>
<pubDate>Sat, 06 Jan 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Strengths and limitations of risk scores in cardiovascular prevention</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38184761/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jan 7;45(2):75-78. doi: 10.1093/eurheartj/ehad850.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38184761/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38184761</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad850>10.1093/eurheartj/ehad850</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38184761</guid>
<pubDate>Sat, 06 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-01-06</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Strengths and limitations of risk scores in cardiovascular prevention</dc:title>
<dc:identifier>pmid:38184761</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad850</dc:identifier>
</item>
<item>
<title>A programmable reaction-diffusion system for spatiotemporal cell signaling circuit design</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181787/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>Cells self-organize molecules in space and time to generate complex behaviors, but we lack synthetic strategies for engineering spatiotemporal signaling. We present a programmable reaction-diffusion platform for designing protein oscillations, patterns, and circuits in mammalian cells using two bacterial proteins, MinD and MinE (MinDE). MinDE circuits act like "single-cell radios," emitting frequency-barcoded fluorescence signals that can be spectrally isolated and analyzed using digital signal...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Dec 27:S0092-8674(23)01339-9. doi: 10.1016/j.cell.2023.12.007. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cells self-organize molecules in space and time to generate complex behaviors, but we lack synthetic strategies for engineering spatiotemporal signaling. We present a programmable reaction-diffusion platform for designing protein oscillations, patterns, and circuits in mammalian cells using two bacterial proteins, MinD and MinE (MinDE). MinDE circuits act like "single-cell radios," emitting frequency-barcoded fluorescence signals that can be spectrally isolated and analyzed using digital signal processing tools. We define how to genetically program these signals and connect their spatiotemporal dynamics to cell biology using engineerable protein-protein interactions. This enabled us to construct sensitive reporter circuits that broadcast endogenous cell signaling dynamics on a frequency-barcoded imaging channel and to build control signal circuits that synthetically pattern activities in the cell, such as protein condensate assembly and actin filamentation. Our work establishes a paradigm for visualizing, probing, and engineering cellular activities at length and timescales critical for biological function.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181787/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181787</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.007>10.1016/j.cell.2023.12.007</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181787</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Rohith Rajasekaran</dc:creator>
<dc:creator>Chih-Chia Chang</dc:creator>
<dc:creator>Elliott W Z Weix</dc:creator>
<dc:creator>Thomas M Galateo</dc:creator>
<dc:creator>Scott M Coyle</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A programmable reaction-diffusion system for spatiotemporal cell signaling circuit design</dc:title>
<dc:identifier>pmid:38181787</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.007</dc:identifier>
</item>
<item>
<title>Engineering TALE-linked deaminases to facilitate precision adenine base editing in mitochondrial DNA</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181745/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>DddA-derived cytosine base editors (DdCBEs) and transcription activator-like effector (TALE)-linked deaminases (TALEDs) catalyze targeted base editing of mitochondrial DNA (mtDNA) in eukaryotic cells, a method useful for modeling of mitochondrial genetic disorders and developing novel therapeutic modalities. Here, we report that A-to-G-editing TALEDs but not C-to-T-editing DdCBEs induce tens of thousands of transcriptome-wide off-target edits in human cells. To avoid these unwanted RNA edits, we...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 4;187(1):95-109.e26. doi: 10.1016/j.cell.2023.11.035.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DddA-derived cytosine base editors (DdCBEs) and transcription activator-like effector (TALE)-linked deaminases (TALEDs) catalyze targeted base editing of mitochondrial DNA (mtDNA) in eukaryotic cells, a method useful for modeling of mitochondrial genetic disorders and developing novel therapeutic modalities. Here, we report that A-to-G-editing TALEDs but not C-to-T-editing DdCBEs induce tens of thousands of transcriptome-wide off-target edits in human cells. To avoid these unwanted RNA edits, we engineered the substrate-binding site in TadA8e, the deoxy-adenine deaminase in TALEDs, and created TALED variants with fine-tuned deaminase activity. Our engineered TALED variants not only reduced RNA off-target edits by >;99% but also minimized off-target mtDNA mutations and bystander edits at a target site. Unlike wild-type versions, our TALED variants were not cytotoxic and did not cause developmental arrest of mouse embryos. As a result, we obtained mice with pathogenic mtDNA mutations, associated with Leigh syndrome, which showed reduced heart rates.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181745/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181745</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.11.035>10.1016/j.cell.2023.11.035</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181745</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Sung-Ik Cho</dc:creator>
<dc:creator>Kayeong Lim</dc:creator>
<dc:creator>Seongho Hong</dc:creator>
<dc:creator>Jaesuk Lee</dc:creator>
<dc:creator>Annie Kim</dc:creator>
<dc:creator>Chae Jin Lim</dc:creator>
<dc:creator>Seungmin Ryou</dc:creator>
<dc:creator>Ji Min Lee</dc:creator>
<dc:creator>Young Geun Mok</dc:creator>
<dc:creator>Eugene Chung</dc:creator>
<dc:creator>Sanghun Kim</dc:creator>
<dc:creator>Seunghun Han</dc:creator>
<dc:creator>Sang-Mi Cho</dc:creator>
<dc:creator>Jieun Kim</dc:creator>
<dc:creator>Eun-Kyoung Kim</dc:creator>
<dc:creator>Ki-Hoan Nam</dc:creator>
<dc:creator>Yeji Oh</dc:creator>
<dc:creator>Minkyung Choi</dc:creator>
<dc:creator>Tae Hyeon An</dc:creator>
<dc:creator>Kyoung-Jin Oh</dc:creator>
<dc:creator>Seonghyun Lee</dc:creator>
<dc:creator>Hyunji Lee</dc:creator>
<dc:creator>Jin-Soo Kim</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Engineering TALE-linked deaminases to facilitate precision adenine base editing in mitochondrial DNA</dc:title>
<dc:identifier>pmid:38181745</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.11.035</dc:identifier>
</item>
<item>
<title>Constructing human neural circuits in living systems by transplantation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181744/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>Our understanding of how the brain assembles its circuits and how this goes awry in disease remains incomplete. There has been great progress in generating human neurons from stem cells in vitro and, more recently, in constructing circuits with human cells in vivo by transplantation. Here, I highlight approaches, promises, and challenges of growing human neurons in living animals to study human development and disease.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 4;187(1):8-13. doi: 10.1016/j.cell.2023.12.008.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Our understanding of how the brain assembles its circuits and how this goes awry in disease remains incomplete. There has been great progress in generating human neurons from stem cells in vitro and, more recently, in constructing circuits with human cells in vivo by transplantation. Here, I highlight approaches, promises, and challenges of growing human neurons in living animals to study human development and disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181744/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181744</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.008>10.1016/j.cell.2023.12.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181744</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Sergiu P Pașca</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Constructing human neural circuits in living systems by transplantation</dc:title>
<dc:identifier>pmid:38181744</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.008</dc:identifier>
</item>
<item>
<title>Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181743/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>The CD4-binding site (CD4bs) is a conserved epitope on HIV-1 envelope (Env) that can be targeted by protective broadly neutralizing antibodies (bnAbs). HIV-1 vaccines have not elicited CD4bs bnAbs for many reasons, including the occlusion of CD4bs by glycans, expansion of appropriate naive B cells with immunogens, and selection of functional antibody mutations. Here, we demonstrate that immunization of macaques with a CD4bs-targeting immunogen elicits neutralizing bnAb precursors with structural...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 4;187(1):79-94.e24. doi: 10.1016/j.cell.2023.12.002.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The CD4-binding site (CD4bs) is a conserved epitope on HIV-1 envelope (Env) that can be targeted by protective broadly neutralizing antibodies (bnAbs). HIV-1 vaccines have not elicited CD4bs bnAbs for many reasons, including the occlusion of CD4bs by glycans, expansion of appropriate naive B cells with immunogens, and selection of functional antibody mutations. Here, we demonstrate that immunization of macaques with a CD4bs-targeting immunogen elicits neutralizing bnAb precursors with structural and genetic features of CD4-mimicking bnAbs. Structures of the CD4bs nAb bound to HIV-1 Env demonstrated binding angles and heavy-chain interactions characteristic of all known human CD4-mimicking bnAbs. Macaque nAb were derived from variable and joining gene segments orthologous to the genes of human VH1-46-class bnAb. This vaccine study initiated in primates the B cells from which CD4bs bnAbs can derive, accomplishing the key first step in the development of an effective HIV-1 vaccine.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181743/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181743</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.002>10.1016/j.cell.2023.12.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181743</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Kevin O Saunders</dc:creator>
<dc:creator>James Counts</dc:creator>
<dc:creator>Bhishem Thakur</dc:creator>
<dc:creator>Victoria Stalls</dc:creator>
<dc:creator>Robert Edwards</dc:creator>
<dc:creator>Kartik Manne</dc:creator>
<dc:creator>Xiaozhi Lu</dc:creator>
<dc:creator>Katayoun Mansouri</dc:creator>
<dc:creator>Yue Chen</dc:creator>
<dc:creator>Rob Parks</dc:creator>
<dc:creator>Maggie Barr</dc:creator>
<dc:creator>Laura Sutherland</dc:creator>
<dc:creator>Joena Bal</dc:creator>
<dc:creator>Nicholas Havill</dc:creator>
<dc:creator>Haiyan Chen</dc:creator>
<dc:creator>Emily Machiele</dc:creator>
<dc:creator>Nolan Jamieson</dc:creator>
<dc:creator>Bhavna Hora</dc:creator>
<dc:creator>Megan Kopp</dc:creator>
<dc:creator>Katarzyna Janowska</dc:creator>
<dc:creator>Kara Anasti</dc:creator>
<dc:creator>Chuancang Jiang</dc:creator>
<dc:creator>Elizabeth Van Itallie</dc:creator>
<dc:creator>Sravani Venkatayogi</dc:creator>
<dc:creator>Amanda Eaton</dc:creator>
<dc:creator>Rory Henderson</dc:creator>
<dc:creator>Christopher Barbosa</dc:creator>
<dc:creator>S Munir Alam</dc:creator>
<dc:creator>Sampa Santra</dc:creator>
<dc:creator>Drew Weissman</dc:creator>
<dc:creator>M Anthony Moody</dc:creator>
<dc:creator>Derek W Cain</dc:creator>
<dc:creator>Ying K Tam</dc:creator>
<dc:creator>Mark Lewis</dc:creator>
<dc:creator>Wilton B Williams</dc:creator>
<dc:creator>Kevin Wiehe</dc:creator>
<dc:creator>David C Montefiori</dc:creator>
<dc:creator>Priyamvada Acharya</dc:creator>
<dc:creator>Barton F Haynes</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques</dc:title>
<dc:identifier>pmid:38181743</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.002</dc:identifier>
</item>
<item>
<title>The innovation menagerie: New institutional structures are expanding horizons for early-stage research</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181742/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>Academia is a vital source of innovation and discovery, but it faces challenges in funding and coordination. These challenges limit the scope and impact of academic research. Now, philanthropists and governments are exploring new institutional structures and funding strategies, with the goal of unleashing scientific discovery.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 4;187(1):3-7. doi: 10.1016/j.cell.2023.11.039.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Academia is a vital source of innovation and discovery, but it faces challenges in funding and coordination. These challenges limit the scope and impact of academic research. Now, philanthropists and governments are exploring new institutional structures and funding strategies, with the goal of unleashing scientific discovery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181742/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181742</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.11.039>10.1016/j.cell.2023.11.039</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181742</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Samuel G Rodriques</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The innovation menagerie: New institutional structures are expanding horizons for early-stage research</dc:title>
<dc:identifier>pmid:38181742</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.11.039</dc:identifier>
</item>
<item>
<title>Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181741/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>We performed comprehensive proteogenomic characterization of small cell lung cancer (SCLC) using paired tumors and adjacent lung tissues from 112 treatment-naive patients who underwent surgical resection. Integrated multi-omics analysis illustrated cancer biology downstream of genetic aberrations and highlighted oncogenic roles of FAT1 mutation, RB1 deletion, and chromosome 5q loss. Two prognostic biomarkers, HMGB3 and CASP10, were identified. Overexpression of HMGB3 promoted SCLC cell migration...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 4;187(1):184-203.e28. doi: 10.1016/j.cell.2023.12.004.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">We performed comprehensive proteogenomic characterization of small cell lung cancer (SCLC) using paired tumors and adjacent lung tissues from 112 treatment-naive patients who underwent surgical resection. Integrated multi-omics analysis illustrated cancer biology downstream of genetic aberrations and highlighted oncogenic roles of FAT1 mutation, RB1 deletion, and chromosome 5q loss. Two prognostic biomarkers, HMGB3 and CASP10, were identified. Overexpression of HMGB3 promoted SCLC cell migration via transcriptional regulation of cell junction-related genes. Immune landscape characterization revealed an association between ZFHX3 mutation and high immune infiltration and underscored a potential immunosuppressive role of elevated DNA damage response activity via inhibition of the cGAS-STING pathway. Multi-omics clustering identified four subtypes with subtype-specific therapeutic vulnerabilities. Cell line and patient-derived xenograft-based drug tests validated the specific therapeutic responses predicted by multi-omics subtyping. This study provides a valuable resource as well as insights to better understand SCLC biology and improve clinical practice.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181741/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181741</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.004>10.1016/j.cell.2023.12.004</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181741</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Qian Liu</dc:creator>
<dc:creator>Jing Zhang</dc:creator>
<dc:creator>Chenchen Guo</dc:creator>
<dc:creator>Mengcheng Wang</dc:creator>
<dc:creator>Chenfei Wang</dc:creator>
<dc:creator>Yilv Yan</dc:creator>
<dc:creator>Liangdong Sun</dc:creator>
<dc:creator>Di Wang</dc:creator>
<dc:creator>Lele Zhang</dc:creator>
<dc:creator>Huansha Yu</dc:creator>
<dc:creator>Likun Hou</dc:creator>
<dc:creator>Chunyan Wu</dc:creator>
<dc:creator>Yuming Zhu</dc:creator>
<dc:creator>Gening Jiang</dc:creator>
<dc:creator>Hongwen Zhu</dc:creator>
<dc:creator>Yanting Zhou</dc:creator>
<dc:creator>Shanhua Fang</dc:creator>
<dc:creator>Tengfei Zhang</dc:creator>
<dc:creator>Liang Hu</dc:creator>
<dc:creator>Junqiang Li</dc:creator>
<dc:creator>Yansheng Liu</dc:creator>
<dc:creator>Hui Zhang</dc:creator>
<dc:creator>Bing Zhang</dc:creator>
<dc:creator>Li Ding</dc:creator>
<dc:creator>Ana I Robles</dc:creator>
<dc:creator>Henry Rodriguez</dc:creator>
<dc:creator>Daming Gao</dc:creator>
<dc:creator>Hongbin Ji</dc:creator>
<dc:creator>Hu Zhou</dc:creator>
<dc:creator>Peng Zhang</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies</dc:title>
<dc:identifier>pmid:38181741</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.004</dc:identifier>
</item>
<item>
<title>Microbial transmission in the social microbiome and host health and disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181740/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>Although social interactions are known to drive pathogen transmission, the contributions of socially transmissible host-associated mutualists and commensals to host health and disease remain poorly explored. We use the concept of the social microbiome-the microbial metacommunity of a social network of hosts-to analyze the implications of social microbial transmission for host health and disease. We investigate the contributions of socially transmissible microbes to both eco-evolutionary...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 4;187(1):17-43. doi: 10.1016/j.cell.2023.12.014.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Although social interactions are known to drive pathogen transmission, the contributions of socially transmissible host-associated mutualists and commensals to host health and disease remain poorly explored. We use the concept of the social microbiome-the microbial metacommunity of a social network of hosts-to analyze the implications of social microbial transmission for host health and disease. We investigate the contributions of socially transmissible microbes to both eco-evolutionary microbiome community processes (colonization resistance, the evolution of virulence, and reactions to ecological disturbance) and microbial transmission-based processes (transmission of microbes with metabolic and immune effects, inter-specific transmission, transmission of antibiotic-resistant microbes, and transmission of viruses). We consider the implications of social microbial transmission for communicable and non-communicable diseases and evaluate the importance of a socially transmissible component underlying canonically non-communicable diseases. The social transmission of mutualists and commensals may play a significant, under-appreciated role in the social determinants of health and may act as a hidden force in social evolution.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181740/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181740</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.014>10.1016/j.cell.2023.12.014</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181740</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Amar Sarkar</dc:creator>
<dc:creator>Cameron J A McInroy</dc:creator>
<dc:creator>Siobhán Harty</dc:creator>
<dc:creator>Aura Raulo</dc:creator>
<dc:creator>Neil G O Ibata</dc:creator>
<dc:creator>Mireia Valles-Colomer</dc:creator>
<dc:creator>Katerina V-A Johnson</dc:creator>
<dc:creator>Ilana L Brito</dc:creator>
<dc:creator>Joseph Henrich</dc:creator>
<dc:creator>Elizabeth A Archie</dc:creator>
<dc:creator>Luis B Barreiro</dc:creator>
<dc:creator>Francesca S Gazzaniga</dc:creator>
<dc:creator>B Brett Finlay</dc:creator>
<dc:creator>Eugene V Koonin</dc:creator>
<dc:creator>Rachel N Carmody</dc:creator>
<dc:creator>Andrew H Moeller</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Microbial transmission in the social microbiome and host health and disease</dc:title>
<dc:identifier>pmid:38181740</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.014</dc:identifier>
</item>
<item>
<title>A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181739/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>To better understand intrinsic resistance to immune checkpoint blockade (ICB), we established a comprehensive view of the cellular architecture of the treatment-naive melanoma ecosystem and studied its evolution under ICB. Using single-cell, spatial multi-omics, we showed that the tumor microenvironment promotes the emergence of a complex melanoma transcriptomic landscape. Melanoma cells harboring a mesenchymal-like (MES) state, a population known to confer resistance to targeted therapy, were...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 4;187(1):166-183.e25. doi: 10.1016/j.cell.2023.11.037.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">To better understand intrinsic resistance to immune checkpoint blockade (ICB), we established a comprehensive view of the cellular architecture of the treatment-naive melanoma ecosystem and studied its evolution under ICB. Using single-cell, spatial multi-omics, we showed that the tumor microenvironment promotes the emergence of a complex melanoma transcriptomic landscape. Melanoma cells harboring a mesenchymal-like (MES) state, a population known to confer resistance to targeted therapy, were significantly enriched in early on-treatment biopsies from non-responders to ICB. TCF4 serves as the hub of this landscape by being a master regulator of the MES signature and a suppressor of the melanocytic and antigen presentation transcriptional programs. Targeting TCF4 genetically or pharmacologically, using a bromodomain inhibitor, increased immunogenicity and sensitivity of MES cells to ICB and targeted therapy. We thereby uncovered a TCF4-dependent regulatory network that orchestrates multiple transcriptional programs and contributes to resistance to both targeted therapy and ICB in melanoma.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181739/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181739</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.11.037>10.1016/j.cell.2023.11.037</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181739</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Joanna Pozniak</dc:creator>
<dc:creator>Dennis Pedri</dc:creator>
<dc:creator>Ewout Landeloos</dc:creator>
<dc:creator>Yannick Van Herck</dc:creator>
<dc:creator>Asier Antoranz</dc:creator>
<dc:creator>Lukas Vanwynsberghe</dc:creator>
<dc:creator>Ada Nowosad</dc:creator>
<dc:creator>Niccolò Roda</dc:creator>
<dc:creator>Samira Makhzami</dc:creator>
<dc:creator>Greet Bervoets</dc:creator>
<dc:creator>Lucas Ferreira Maciel</dc:creator>
<dc:creator>Carlos Ariel Pulido-Vicuña</dc:creator>
<dc:creator>Lotte Pollaris</dc:creator>
<dc:creator>Ruth Seurinck</dc:creator>
<dc:creator>Fang Zhao</dc:creator>
<dc:creator>Karine Flem-Karlsen</dc:creator>
<dc:creator>William Damsky</dc:creator>
<dc:creator>Limin Chen</dc:creator>
<dc:creator>Despoina Karagianni</dc:creator>
<dc:creator>Sonia Cinque</dc:creator>
<dc:creator>Sam Kint</dc:creator>
<dc:creator>Katy Vandereyken</dc:creator>
<dc:creator>Benjamin Rombaut</dc:creator>
<dc:creator>Thierry Voet</dc:creator>
<dc:creator>Frank Vernaillen</dc:creator>
<dc:creator>Wim Annaert</dc:creator>
<dc:creator>Diether Lambrechts</dc:creator>
<dc:creator>Veerle Boecxstaens</dc:creator>
<dc:creator>Yvan Saeys</dc:creator>
<dc:creator>Joost van den Oord</dc:creator>
<dc:creator>Francesca Bosisio</dc:creator>
<dc:creator>Panagiotis Karras</dc:creator>
<dc:creator>A Hunter Shain</dc:creator>
<dc:creator>Marcus Bosenberg</dc:creator>
<dc:creator>Eleonora Leucci</dc:creator>
<dc:creator>Annette Paschen</dc:creator>
<dc:creator>Florian Rambow</dc:creator>
<dc:creator>Oliver Bechter</dc:creator>
<dc:creator>Jean-Christophe Marine</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma</dc:title>
<dc:identifier>pmid:38181739</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.11.037</dc:identifier>
</item>
<item>
<title>Proteomics: A new dimension to decode small cell lung cancer</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181738/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>Small cell lung cancer (SCLC) is a recalcitrant malignancy. Conquering it will require deep insight into its biology. In this issue of Cell, Liu and colleagues describe proteomic and phosphoproteomic landscapes of resected SCLC tumors and illustrate the potential of this knowledge to identify new SCLC vulnerabilities.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 4;187(1):14-16. doi: 10.1016/j.cell.2023.11.042.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Small cell lung cancer (SCLC) is a recalcitrant malignancy. Conquering it will require deep insight into its biology. In this issue of Cell, Liu and colleagues describe proteomic and phosphoproteomic landscapes of resected SCLC tumors and illustrate the potential of this knowledge to identify new SCLC vulnerabilities.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181738/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181738</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.11.042>10.1016/j.cell.2023.11.042</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181738</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Haobin Chen</dc:creator>
<dc:creator>Benjamin J Drapkin</dc:creator>
<dc:creator>John D Minna</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Proteomics: A new dimension to decode small cell lung cancer</dc:title>
<dc:identifier>pmid:38181738</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.11.042</dc:identifier>
</item>
<item>
<title>XIST directly regulates X-linked and autosomal genes in naive human pluripotent cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181737/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>X chromosome inactivation (XCI) serves as a paradigm for RNA-mediated regulation of gene expression, wherein the long non-coding RNA XIST spreads across the X chromosome in cis to mediate gene silencing chromosome-wide. In female naive human pluripotent stem cells (hPSCs), XIST is in a dispersed configuration, and XCI does not occur, raising questions about XIST's function. We found that XIST spreads across the X chromosome and induces dampening of X-linked gene expression in naive hPSCs....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 4;187(1):110-129.e31. doi: 10.1016/j.cell.2023.11.033.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">X chromosome inactivation (XCI) serves as a paradigm for RNA-mediated regulation of gene expression, wherein the long non-coding RNA XIST spreads across the X chromosome in cis to mediate gene silencing chromosome-wide. In female naive human pluripotent stem cells (hPSCs), XIST is in a dispersed configuration, and XCI does not occur, raising questions about XIST's function. We found that XIST spreads across the X chromosome and induces dampening of X-linked gene expression in naive hPSCs. Surprisingly, XIST also targets specific autosomal regions, where it induces repressive chromatin changes and gene expression dampening. Thereby, XIST equalizes X-linked gene dosage between male and female cells while inducing differences in autosomes. The dispersed Xist configuration and autosomal localization also occur transiently during XCI initiation in mouse PSCs. Together, our study identifies XIST as the regulator of X chromosome dampening, uncovers an evolutionarily conserved trans-acting role of XIST/Xist, and reveals a correlation between XIST/Xist dispersal and autosomal targeting.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181737/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181737</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.11.033>10.1016/j.cell.2023.11.033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181737</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Iris Dror</dc:creator>
<dc:creator>Tsotne Chitiashvili</dc:creator>
<dc:creator>Shawn Y X Tan</dc:creator>
<dc:creator>Clara T Cano</dc:creator>
<dc:creator>Anna Sahakyan</dc:creator>
<dc:creator>Yolanda Markaki</dc:creator>
<dc:creator>Constantinos Chronis</dc:creator>
<dc:creator>Amanda J Collier</dc:creator>
<dc:creator>Weixian Deng</dc:creator>
<dc:creator>Guohao Liang</dc:creator>
<dc:creator>Yu Sun</dc:creator>
<dc:creator>Anna Afasizheva</dc:creator>
<dc:creator>Jarrett Miller</dc:creator>
<dc:creator>Wen Xiao</dc:creator>
<dc:creator>Douglas L Black</dc:creator>
<dc:creator>Fangyuan Ding</dc:creator>
<dc:creator>Kathrin Plath</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>XIST directly regulates X-linked and autosomal genes in naive human pluripotent cells</dc:title>
<dc:identifier>pmid:38181737</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.11.033</dc:identifier>
</item>
<item>
<title>Cell at fifty</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38181736/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>Fifty years ago, Cell launched with the aspiration of becoming a journal of exciting biology. Today, we begin a year-long celebration of this momentous anniversary. But before we embark on our journey, we first reflect on Cell at fifty and what this anniversary means to us.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 4;187(1):1-2. doi: 10.1016/j.cell.2023.12.009.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Fifty years ago, Cell launched with the aspiration of becoming a journal of exciting biology. Today, we begin a year-long celebration of this momentous anniversary. But before we embark on our journey, we first reflect on Cell at fifty and what this anniversary means to us.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38181736/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38181736</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.009>10.1016/j.cell.2023.12.009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38181736</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>None The Cell Editorial Team</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Cell at fifty</dc:title>
<dc:identifier>pmid:38181736</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.009</dc:identifier>
</item>
<item>
<title>Sox9 Accelerates Vascular Ageing by Regulating Extracellular Matrix Composition and Stiffness</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38179698/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>CONCLUSIONS: These findings highlight the crucial role of ECM structure and composition in regulating VSMC phenotype. We identify a positive feedback cycle, whereby cellular senescence and increased ECM stiffening promote Sox9 expression, which, in turn, drives further ECM modifications to further accelerate stiffening and senescence.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jan 5. doi: 10.1161/CIRCRESAHA.123.323365. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Vascular calcification and increased extracellular matrix (ECM) stiffness are hallmarks of vascular aging. Sox9 (SRY-box transcription factor 9) has been implicated in vascular smooth muscle cell (VSMC) osteo/chondrogenic conversion; however, its relationship with aging and calcification has not been studied.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Immunohistochemistry was performed on human aortic samples from young and aged patients. Young and senescent primary human VSMCs were induced to produce ECM, and Sox9 expression was manipulated using adenoviral overexpression and depletion. ECM properties were characterized using atomic force microscopy and proteomics, and VSMC phenotype on hydrogels and the ECM were examined using confocal microscopy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In vivo, Sox9 was not spatially associated with vascular calcification but correlated with the senescence marker p16. In vitro Sox9 showed mechanosensitive responses with increased expression and nuclear translocation in senescent cells and on stiff matrices. Sox9 was found to regulate ECM stiffness and organization by orchestrating changes in collagen (Col) expression and reducing VSMC contractility, leading to the formation of an ECM that mirrored that of senescent cells. These ECM changes promoted phenotypic modulation of VSMCs, whereby senescent cells plated on ECM synthesized from cells depleted of Sox9 returned to a proliferative state, while proliferating cells on a matrix produced by Sox9 expressing cells showed reduced proliferation and increased DNA damage, reiterating features of senescent cells. LH3 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3) was identified as an Sox9 target and key regulator of ECM stiffness. LH3 is packaged into extracellular vesicles and Sox9 promotes extracellular vesicle secretion, leading to increased LH3 deposition within the ECM.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These findings highlight the crucial role of ECM structure and composition in regulating VSMC phenotype. We identify a positive feedback cycle, whereby cellular senescence and increased ECM stiffening promote Sox9 expression, which, in turn, drives further ECM modifications to further accelerate stiffening and senescence.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.biorxiv.org/content/10.1101/2023.05.03.539285v2; Unique identifier: XXX.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38179698/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38179698</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323365>10.1161/CIRCRESAHA.123.323365</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38179698</guid>
<pubDate>Fri, 05 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Maria Faleeva</dc:creator>
<dc:creator>Sadia Ahmad</dc:creator>
<dc:creator>Konstantinos Theofilatos</dc:creator>
<dc:creator>Steven Lynham</dc:creator>
<dc:creator>Gabriel Watson</dc:creator>
<dc:creator>Meredith Whitehead</dc:creator>
<dc:creator>Emilie Marhuenda</dc:creator>
<dc:creator>Thomas Iskratsch</dc:creator>
<dc:creator>Susan Cox</dc:creator>
<dc:creator>Catherine M Shanahan</dc:creator>
<dc:date>2024-01-05</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Sox9 Accelerates Vascular Ageing by Regulating Extracellular Matrix Composition and Stiffness</dc:title>
<dc:identifier>pmid:38179698</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323365</dc:identifier>
</item>
<item>
<title>Atherosclerotic plaque stabilization and regression: a review of clinical evidence</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38177454/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>Atherosclerotic plaque results from a complex interplay between lipid deposition, inflammatory changes, cell migration and arterial wall injury. Over the past two decades, clinical trials utilizing invasive arterial imaging modalities, such as intravascular ultrasonography, have shown that reducing levels of atherogenic lipoproteins, mainly serum LDL-cholesterol (LDL-C), to very low levels can safely reduce overall atherosclerotic plaque burden and favourably modify plaque composition....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Jan 4. doi: 10.1038/s41569-023-00979-8. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Atherosclerotic plaque results from a complex interplay between lipid deposition, inflammatory changes, cell migration and arterial wall injury. Over the past two decades, clinical trials utilizing invasive arterial imaging modalities, such as intravascular ultrasonography, have shown that reducing levels of atherogenic lipoproteins, mainly serum LDL-cholesterol (LDL-C), to very low levels can safely reduce overall atherosclerotic plaque burden and favourably modify plaque composition. Classically, this outcome has been achieved with intensive statin therapy. Since 2016, newer and potent lipid-lowering strategies, such as proprotein convertase subtilisin-kexin type 9 inhibition, have shown incremental effects on plaque regression and risk of clinical events. Despite maximal reduction in plasma LDL-C levels, considerable residual cardiovascular risk remains in some patients. Therefore, there is a need to study therapeutic approaches that address residual risk beyond LDL-C reduction to promote plaque stabilization or regression. Contemporary imaging modalities, such as coronary computed tomography angiography, enable non-invasive assessment of the overall atherosclerotic plaque burden as well as of certain local plaque characteristics. This technology could allow further study of plaque stabilization and regression using novel therapeutic approaches. Non-invasive plaque assessment might also offer the potential to guide personalized management strategies if validated for this purpose.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38177454/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38177454</a> | DOI:<a href=https://doi.org/10.1038/s41569-023-00979-8>10.1038/s41569-023-00979-8</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38177454</guid>
<pubDate>Thu, 04 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Ashish Sarraju</dc:creator>
<dc:creator>Steven E Nissen</dc:creator>
<dc:date>2024-01-04</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Atherosclerotic plaque stabilization and regression: a review of clinical evidence</dc:title>
<dc:identifier>pmid:38177454</dc:identifier>
<dc:identifier>doi:10.1038/s41569-023-00979-8</dc:identifier>
</item>
<item>
<title>Structural and functional basis of VLDLR usage by Eastern equine encephalitis virus</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38176410/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>The very-low-density lipoprotein receptor (VLDLR) comprises eight LDLR type A (LA) domains and supports entry of distantly related alphaviruses, including Eastern equine encephalitis virus (EEEV) and Semliki Forest virus (SFV). Here, by resolving multiple cryo-electron microscopy structures of EEEV-VLDLR complexes and performing mutagenesis and functional studies, we show that EEEV uses multiple sites (E1/E2 cleft and E2 A domain) to engage more than one LA domain simultaneously. However, no...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Dec 28:S0092-8674(23)01318-1. doi: 10.1016/j.cell.2023.11.031. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The very-low-density lipoprotein receptor (VLDLR) comprises eight LDLR type A (LA) domains and supports entry of distantly related alphaviruses, including Eastern equine encephalitis virus (EEEV) and Semliki Forest virus (SFV). Here, by resolving multiple cryo-electron microscopy structures of EEEV-VLDLR complexes and performing mutagenesis and functional studies, we show that EEEV uses multiple sites (E1/E2 cleft and E2 A domain) to engage more than one LA domain simultaneously. However, no single LA domain is necessary or sufficient to support efficient EEEV infection. Whereas all EEEV strains show conservation of two VLDLR-binding sites, the EEEV PE-6 strain and a few other EEE complex members feature a single amino acid substitution that enables binding of LA domains to an additional site on the E2 B domain. These structural and functional analyses informed the design of a minimal VLDLR decoy receptor that neutralizes EEEV infection and protects mice from lethal challenge.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38176410/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38176410</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.11.031>10.1016/j.cell.2023.11.031</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38176410</guid>
<pubDate>Thu, 04 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Lucas J Adams</dc:creator>
<dc:creator>Saravanan Raju</dc:creator>
<dc:creator>Hongming Ma</dc:creator>
<dc:creator>Theron Gilliland</dc:creator>
<dc:creator>Douglas S Reed</dc:creator>
<dc:creator>William B Klimstra</dc:creator>
<dc:creator>Daved H Fremont</dc:creator>
<dc:creator>Michael S Diamond</dc:creator>
<dc:date>2024-01-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Structural and functional basis of VLDLR usage by Eastern equine encephalitis virus</dc:title>
<dc:identifier>pmid:38176410</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.11.031</dc:identifier>
</item>
<item>
<title>Legumain Regulates Regulatory T Cells in Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38175912/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jan 5;134(1):30-32. doi: 10.1161/CIRCRESAHA.123.324010. Epub 2024 Jan 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38175912/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38175912</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10768802/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">PMC10768802</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.324010>10.1161/CIRCRESAHA.123.324010</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38175912</guid>
<pubDate>Thu, 04 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Matthew R Alexander</dc:creator>
<dc:creator>David G Harrison</dc:creator>
<dc:date>2024-01-04</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Legumain Regulates Regulatory T Cells in Hypertension</dc:title>
<dc:identifier>pmid:38175912</dc:identifier>
<dc:identifier>pmc:PMC10768802</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.324010</dc:identifier>
</item>
<item>
<title>Shedding Light on the Roles of Ceramide in Human Microvascular Function</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38175911/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jan 5;134(1):97-99. doi: 10.1161/CIRCRESAHA.123.323868. Epub 2024 Jan 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38175911/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38175911</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323868>10.1161/CIRCRESAHA.123.323868</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38175911</guid>
<pubDate>Thu, 04 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Charles D Searles</dc:creator>
<dc:date>2024-01-04</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Shedding Light on the Roles of Ceramide in Human Microvascular Function</dc:title>
<dc:identifier>pmid:38175911</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323868</dc:identifier>
</item>
<item>
<title>Exploring the Connection Between Relaxed Myosin States and the Anrep Effect</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38175910/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>The Anrep effect is an adaptive response that increases left ventricular contractility following an acute rise in afterload. Although the mechanistic origin remains undefined, recent findings suggest a two-phase activation of resting myosin for contraction, involving strain-sensitive and posttranslational phases. We propose that this mobilization represents a transition among the relaxed states of myosin-specifically, from the super-relaxed (SRX) to the disordered-relaxed (DRX)-with DRX myosin...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jan 5;134(1):117-134. doi: 10.1161/CIRCRESAHA.123.323173. Epub 2024 Jan 4.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The Anrep effect is an adaptive response that increases left ventricular contractility following an acute rise in afterload. Although the mechanistic origin remains undefined, recent findings suggest a two-phase activation of resting myosin for contraction, involving strain-sensitive and posttranslational phases. We propose that this mobilization represents a transition among the relaxed states of myosin-specifically, from the super-relaxed (SRX) to the disordered-relaxed (DRX)-with DRX myosin ready to participate in force generation. This hypothesis offers a unified explanation that connects myosin's SRX-DRX equilibrium and the Anrep effect as parts of a singular phenomenon. We underscore the significance of this equilibrium in modulating contractility, primarily studied in the context of hypertrophic cardiomyopathy, the most common inherited cardiomyopathy associated with diastolic dysfunction, hypercontractility, and left ventricular hypertrophy. As we posit that the cellular basis of the Anrep effect relies on a two-phased transition of myosin from the SRX to the contraction-ready DRX configuration, any dysregulation in this equilibrium may result in the pathological manifestation of the Anrep phenomenon. For instance, in hypertrophic cardiomyopathy, hypercontractility is linked to a considerable shift of myosin to the DRX state, implying a persistent activation of the Anrep effect. These valuable insights call for additional research to uncover a clinical Anrep fingerprint in pathological states. Here, we demonstrate through noninvasive echocardiographic pressure-volume measurements that this fingerprint is evident in 12 patients with hypertrophic obstructive cardiomyopathy before septal myocardial ablation. This unique signature is characterized by enhanced contractility, indicated by a leftward shift and steepening of the end-systolic pressure-volume relationship, and a prolonged systolic ejection time adjusted for heart rate, which reverses post-procedure. The clinical application of this concept has potential implications beyond hypertrophic cardiomyopathy, extending to other genetic cardiomyopathies and even noncongenital heart diseases with complex etiologies across a broad spectrum of left ventricular ejection fractions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38175910/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38175910</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323173>10.1161/CIRCRESAHA.123.323173</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38175910</guid>
<pubDate>Thu, 04 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Vasco Sequeira</dc:creator>
<dc:creator>Christoph Maack</dc:creator>
<dc:creator>Gert-Hinrich Reil</dc:creator>
<dc:creator>Jan-Christian Reil</dc:creator>
<dc:date>2024-01-04</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Exploring the Connection Between Relaxed Myosin States and the Anrep Effect</dc:title>
<dc:identifier>pmid:38175910</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323173</dc:identifier>
</item>
<item>
<title>Editors and Editorial Board</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38175909/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jan 5;134(1):1. doi: 10.1161/RES.0000000000000652. Epub 2024 Jan 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38175909/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38175909</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000652>10.1161/RES.0000000000000652</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38175909</guid>
<pubDate>Thu, 04 Jan 2024 06:00:00 -0500</pubDate>
<dc:date>2024-01-04</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Editors and Editorial Board</dc:title>
<dc:identifier>pmid:38175909</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000652</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38175907/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jan 5;134(1):3-5. doi: 10.1161/RES.0000000000000651. Epub 2024 Jan 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38175907/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38175907</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000651>10.1161/RES.0000000000000651</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38175907</guid>
<pubDate>Thu, 04 Jan 2024 06:00:00 -0500</pubDate>
<dc:date>2024-01-04</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:38175907</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000651</dc:identifier>
</item>
<item>
<title>Circulation Research and 70 Years of Basic Science: Examining the Past and Looking Forward to the Future</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38175906/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240107090717&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jan 5;134(1):6-8. doi: 10.1161/CIRCRESAHA.123.323177. Epub 2024 Jan 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38175906/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240107090717&v=2.18.0">38175906</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323177>10.1161/CIRCRESAHA.123.323177</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38175906</guid>
<pubDate>Thu, 04 Jan 2024 06:00:00 -0500</pubDate>
<dc:creator>Jane E Freedman</dc:creator>
<dc:date>2024-01-04</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Circulation Research and 70 Years of Basic Science: Examining the Past and Looking Forward to the Future</dc:title>
<dc:identifier>pmid:38175906</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323177</dc:identifier>
</item>




























</channel>
</rss>